— Know what they know.
Not Investment Advice

PLSH OTC

Panacea Life Sciences Holdings, Inc.
1W: +6.2% 1M: -15.0% 3M: +6.2% YTD: +70.0% 1Y: +14.9% 3Y: -75.7%
$0.09
+0.03 (+41.67%)
 
Weekly Expected Move ±29.6%
$0 $0 $0 $0 $0
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 40 · $1.8M mcap · 10M float · 0.190% daily turnover · Short 40% of daily vol

📊 Key Metrics

TTM
$0M
Revenue
-90.2% YoY
$-6M
Net Income
-272.0% YoY
$0M
Free Cash Flow
-71.6% YoY
99.0%
Gross Margin
-153.6%
Op. Margin
-1581.6%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE128.5%
ROA-139.0%
ROIC-48.4%

Valuation

P/E-0.8
P/B4.6
EV/EBITDA-1.1

Leverage

Debt/Equity0.17
Current Ratio2.30
Interest Cov.-20.4x

Quality Scores

Piotroski F5/9
Altman Z-35.78
Beneish M-195.76

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms